A brief account is given of the history and incidence of bovine pasteurellosis in Kenya. Strains of Past. boviseptica isolated from outbreaks in Kenya conform in general bacteriological details with one another and with two strains obtained from the National Collection of Type Cultures. Sera produced from rabbits by multi-inoculation with antigens variously prepared from Kenya and N.C.T.C. strains were of no value in typing these strains by the agglutination technique. Such strains were shown to be immunologically similar on the basis of cross protection tests in laboratory animals. The viability of these strains under varying conditions was determined as was their capacity to undergo bacterial mutation in differing cultural environment. The comparative virulence of strains of Kenya and N.C.T.C. origin was compared both in cattle and in laboratory animals. These strains were found to be generally resistant, on in vitro tests, to a wide range of drugs of the sulphonamide series, but sensitive to penicillin sodium salt G, Streptomycin and Aureomycin. However, in vivo tests in rabbits given a small infective dose of virulent culture of a selected strain showed the penicillin salt to be without effect in controlling the experimental disease. Experiments in immunology showed that rabbits may be highly immunised by heat-treated vaccine prepared from Past. boviseptica strains selected through virtue of virulence and rich capsular content, and the same vaccine was found to have a high protective value in cattle challenged subsequently by virulent culture which was lethal in controls. A formalinised broth culture vaccine in use in Kenya was found to be of no value, on standard dosage, in the protection of cattle and laboratory animals when challenged later with virulent culture. A concentrated formalinised vaccine, prepared from strains of high virulence and of rich capsular content was found to confer a high order of immunity both in cattle and laboratory animals. Fully susceptible cattle could be protected against a virulent infection, that killed all controls, up to a period of one year following vaccination. Particulars of this vaccine, its method of preparation and the biological standards prescribed for its use in the field are described. Experiments were conducted to investigate other methods of prophylaxis against bovine pasteurellosis, viz., chick embryo vaccine, aggressin, immune serum, filtrate of broth culture, and saponin vaccine. Chick embryo vaccine and aggressin were of limited value and did not compare in immunising value with the new concentrated formalinised vaccine. Immune serum was of doubtful value as a prophylactic in cattle and laboratory animals. Saponin vaccine had no value. Early success attended a vaccine prepared from a rough avirulent strain of Past. boviseptica of Kenya origin and a high degree of immunity could be conferred in cattle and rabbits with this vaccine. It was not possible to maintain the avirulent rough characters of this strain through successive subcultures. If this could be done, the experiments undertaken indicate that such a vaccine would be of the greatest value in the protection of cattle against bovine pasteurellosis.